These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37450541)

  • 1. Influence of chronic liver diseases on the course and outcome of COVID-19.
    Mitrovic N; Sabanovic M; Vujovic A; Jovanovic J; Nikolic N; Jug M; Todorovic N; Filipovic A; Milosevic I
    PLoS One; 2023; 18(7):e0288350. PubMed ID: 37450541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
    PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and the liver: Are footprints still there?
    Gupta T; Sharma H
    World J Gastroenterol; 2023 Jan; 29(4):656-669. PubMed ID: 36742164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 in Individuals with Chronic Liver Diseases.
    Toutoudaki K; Androutsakos T
    J Gastrointestin Liver Dis; 2024 Mar; 33(1):7-10. PubMed ID: 38554411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease.
    Horbal SR; Belancourt PX; Zhang P; Holcombe SA; Saini S; Wang SC; Sales AE; Su GL
    Dig Dis Sci; 2024 Jul; 69(7):2681-2690. PubMed ID: 38653948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality from chronic liver disease: Recent trends and impact of the COVID-19 pandemic.
    Fedeli U; Barbiellini Amidei C; Casotto V; Grande E; Saia M; Zanetto A; Russo FP
    World J Gastroenterol; 2023 Jul; 29(26):4166-4173. PubMed ID: 37475843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the correlation between COVID-19 and the progression of chronic liver disease.
    Philips CA; Madhu D; Augustine P
    Expert Rev Gastroenterol Hepatol; 2023; 17(6):603-613. PubMed ID: 37086388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation.
    Alqahtani SA; Aljumah AA; Hashim A; Alenazi TH; AlJawad M; Al Hamoudi WK; Alghamdi MY
    Ann Saudi Med; 2020; 40(4):273-280. PubMed ID: 32564624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No impact of COVID-19 epidemic on decompensation of alcoholic liver disease: Results from a single-centre in Milan.
    Masetti C; Colapietro F; Voza A; Aghemo A
    Liver Int; 2022 Nov; 42(11):2581-2582. PubMed ID: 36066183
    [No Abstract]   [Full Text] [Related]  

  • 10. Poor outcomes in patients with cirrhosis and Corona Virus Disease-19.
    Shalimar ; Elhence A; Vaishnav M; Kumar R; Pathak P; Soni KD; Aggarwal R; Soneja M; Jorwal P; Kumar A; Khanna P; Singh AK; Biswas A; Nischal N; Dar L; Choudhary A; Rangarajan K; Mohan A; Acharya P; Nayak B; Gunjan D; Saraya A; Mahapatra S; Makharia G; Trikha A; Garg P
    Indian J Gastroenterol; 2020 Jun; 39(3):285-291. PubMed ID: 32803716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type and cause of liver disease in Korea: single-center experience, 2005-2010.
    Lee SS; Byoun YS; Jeong SH; Kim YM; Gil H; Min BY; Seong MH; Jang ES; Kim JW
    Clin Mol Hepatol; 2012 Sep; 18(3):309-15. PubMed ID: 23091812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.
    Tokushige K; Hashimoto E; Horie Y; Taniai M; Higuchi S
    J Gastroenterol; 2011 Oct; 46(10):1230-7. PubMed ID: 21748549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver diseases: Perspective from the Philippines.
    Ornos ED; Murillo KJ; Ong JP
    Ann Hepatol; 2023; 28(3):101085. PubMed ID: 36889673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of COVID-19 on patients with compensated chronic liver diseases.
    Ji D; Zhang D; Yang T; Mu J; Zhao P; Xu J; Li C; Cheng G; Wang Y; Chen Z; Qin E; Lau G
    Hepatol Int; 2020 Sep; 14(5):701-710. PubMed ID: 32734407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC.
    Conci S; Cipriani F; Donadon M; Marchitelli I; Ardito F; Famularo S; Perri P; Iaria M; Ansaloni L; Zanello M; La Barba G; Patauner S; Pinotti E; Molfino S; Germani P; Romano M; Sciannamea I; Ferrari C; Manzoni A; Troci A; Fumagalli L; Delvecchio A; Floridi A; Memeo R; Chiarelli M; Crespi M; Zimmitti G; Griseri G; Antonucci A; Zanus G; Tarchi P; Baiocchi GL; Zago M; Frena A; Ercolani G; Jovine E; Maestri M; Valle RD; Grazi GL; Romano F; Giuliante F; Torzilli G; Aldrighetti L; Ruzzenente A;
    Eur J Surg Oncol; 2022 Jan; 48(1):103-112. PubMed ID: 34325939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases.
    Stine JG; Wentworth BJ; Zimmet A; Rinella ME; Loomba R; Caldwell SH; Argo CK
    Aliment Pharmacol Ther; 2018 Oct; 48(7):696-703. PubMed ID: 30136293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver manifestations in COVID-19 and the influence of pre-existing liver disease in the course of the infection.
    Guerra Veloz MF; Cordero Ruiz P; Ríos-Villegas MJ; Del Pino Bellido P; Bravo-Ferrer J; Galvés Cordero R; Cadena Herrera ML; Vías Parrado C; Bellido Muñoz F; Vega Rodríguez F; Caunedo Álvarez Á; Rodríguez-Baño J; Carmona Soria I
    Rev Esp Enferm Dig; 2021 Feb; 113(2):103-109. PubMed ID: 33393329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.
    Wong CR; Njei B; Nguyen MH; Nguyen A; Lim JK
    Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1061-1069. PubMed ID: 28960360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global burden of liver disease: 2023 update.
    Devarbhavi H; Asrani SK; Arab JP; Nartey YA; Pose E; Kamath PS
    J Hepatol; 2023 Aug; 79(2):516-537. PubMed ID: 36990226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.